Clinical Trials Directory

Trials / Completed

CompletedNCT06858241

Patient Intake At the 'MOvement and REhabilitation (MO.RE.)

Patient Intake At the 'MOvement and REhabilitation (MO.RE.)' Clinic: a Retrospective Observational Study on the Appropriateness of Access and the Needs Expressed by Patients. (BACKMORE2024)

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Azienda USL Reggio Emilia - IRCCS · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In recent years, there has been an exponential increase in studies regarding the benefits of physical activity in oncology, with significant results on improving both physical and psychological outcomes. When appropriately dosed, physical activity can help individuals with a history of cancer to cope with pain and Cancer-Related Fatigue, and improve their quality of life, both during and after cancer treatments. Given the incidence and prevalence of cancer, along with the increase in survival due to advancements in cancer care, it is becoming increasingly important to promote an active lifestyle. For this reason, in August 2022, the MOvement and REhabilitation (MO.RE.) clinic was opened by the S.C. of MFR, dedicated to individuals with a history of cancer at any stage of treatment, with the aim of offering consultations with an experienced physiotherapist to personalize a physical activity program that can help regain a good quality of life, return to daily activities, and prevent the onset of other diseases and recurrences. The clinic also provides therapeutic education activities, following WHO guidelines, on proper lifestyle for wellness and secondary prevention. The aim of our study is to retrospectively analyze the patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024, in order to describe and evaluate the appropriateness of access to the clinic, the expressed needs, and some clinical and rehabilitative data."

Conditions

Timeline

Start date
2022-08-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2025-03-05
Last updated
2025-03-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06858241. Inclusion in this directory is not an endorsement.